Colinz Laboratories

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue1.761.941.871.761.74
Expenses1.601.791.701.621.55
EBITDA0.200.190.200.190.23
EBIT0.170.160.170.160.20
Profit Before Tax0.160.150.160.150.19
Net Profit0.130.120.120.110.14
Financial Ratios
Operating Profit Margin11.63%10.00%11.17%11.11%14.11%
Net Profit Margin7.56%6.32%6.70%6.43%8.59%
Earning Per Share (Diluted)0.510.480.490.420.54
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ